SMTL ID : 8fv4.1 (1 other biounit)

EGFR(T790M/V948R) in complex with compound 2 (LN5993)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

homo-dimer

Ligands

1 x YAA: N-{(3P)-3-[(4P)-4-(2-acetamidopyridin-4-yl)-2-(methylsulfanyl)-1H-imidazol-5-yl]phenyl}-11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepine-9-carboxamide(Non-covalent)

YAA.1: 24 residues within 4Å: Chain A: L.24, V.32, A.49, I.50, K.51, L.53, M.72, L.83, L.94, M.96, Q.97, L.98, M.99, P.100, G.102, R.147, N.148, L.150, T.160, D.161, F.162, G.163, L.164, L.167 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:A.49, A:K.51, A:L.150, A:L.164, A:L.167 Hydrogen bonds: A:K.51, A:K.51, A:M.99, A:M.99, A:G.102, A:T.160, A:T.160, A:D.161 Water bridges: A:D.161 pi-Stacking: A:F.162

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wittlinger, F. et al., Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors. Commun Chem (2024)

Release Date

2024-01-17

Peptides

Epidermal growth factor receptor: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
B

Epidermal growth factor receptor

Related Entries With Identical Sequence